Edwin Johnson

Publications
Public outreach and news

Articles

Article: PSYCHOPHARMACOLOGY. 2012;223(3):251-258
Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats.
Rezvani AH; Cauley MC; Johnson EC; Gatto GJ; Levin ED
Article: PLOS ONE. 2012;7(7):e39775
Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials.
Featherstone RE; Phillips JM; Thieu T; Ehrlichman RS; Halene TB; Leiser SC; Christian E; Johnson E; Lerman C; Siegel SJ
Article: BEHAVIOURAL BRAIN RESEARCH. 2010;212(2):168-173
Acute pharmacological modulation of mGluR8 reduces measures of anxiety.
Duvoisin RM; Pfankuch T; Wilson JM; Grabell J; Chhajlani V; Brown DG; Johnson E; Raber J
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2009;330(1):212-219
The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor.
Chopra M; Yao Y; Blake TJ; Hampson DR; Johnson EC
Article: ANESTHESIOLOGY. 2006;105(3):521-533
Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors
Jonsson M; Gurley D; Dabrowski M; Larsson O; Johnson EC; Eriksson LI
Article: MOLECULAR PHARMACOLOGY. 2004;66(4):834-842
Molecular basis for the differential agonist affinities of group III metabotropic glutamate receptors.
Rosemond E; Wang M; Yao Y; Storjohann L; Stormann T; Johnson EC; Hampson DR
Article: NEUROPHARMACOLOGY. 2000;39(13):2543-2560
Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells.
Chavez-Noriega LE; Gillespie A; Stauderman KA; Crona JH; Claeps BO; Elliott KJ; Reid RT; Rao TS; Velicelebi G; Harpold MM; Johnson EC; Corey-Naeve J
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1999;290(1):170-181
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.
Varney MA; Cosford ND; Jachec C; Rao SP; Sacaan A; Lin FF; Bleicher L; Santori EM; Flor PJ; Allgeier H; Gasparini F; Kuhn R; Hess SD; Veliçelebi G; Johnson EC
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1999;289(3):1678-1687
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
Article: BIOPHYSICAL JOURNAL. 1999;76(3):1384-1400
Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha1A-containing high-voltage-activated calcium channels.
Hans M; Urrutia A; Deal C; Brust PF; Stauderman K; Ellis SB; Harpold MM; Johnson EC; Williams ME
Article: JOURNAL OF NEUROSCIENCE. 1999;19(5):1610-1619
Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine.
Hans M; Luvisetto S; Williams ME; Spagnolo M; Urrutia A; Tottene A; Brust PF; Johnson EC; Harpold MM; Stauderman KA; Pietrobon D
Article: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 1999;294:20-47
Fluorescence techniques for measuring ion channel activity.
Veliçelebi G; Stauderman KA; Varney MA; Akong M; Hess SD; Johnson EC
Article: JOURNAL OF NEUROCHEMISTRY. 1998;71(5):1953-1968
The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression.
Daggett LP; Johnson EC; Varney MA; Lin FF; Hess SD; Deal CR; Jachec C; Lu CC; Kerner JA; Landwehrmeyer GB; Standaert DG; Young AB; Harpold MM; Veliçelebi G
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1998;285(1):358-370
Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells.
Varney MA; Rao SP; Jachec C; Deal C; Hess SD; Daggett LP; Lin F; Johnson EC; Veliçelebi G
Article: JOURNAL OF NEUROCHEMISTRY. 1998;70(3):1269-1279
Functional characterization of human N-methyl-D-aspartate subtype 1A/2D receptors.
Hess SD; Daggett LP; Deal C; Lu CC; Johnson EC; Veliçelebi G
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1998;284(2):777-789
Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.
Stauderman KA; Mahaffy LS; Akong M; Veliçelebi G; Chavez-Noriega LE; Crona JH; Johnson EC; Elliott KJ; Gillespie A; Reid RT; Adams P; Harpold MM; Corey-Naeve J
Article: VISUAL NEUROSCIENCE. 1998;15(1):105-112
Rescue of excitation by inositol following Li(+)-induced block in Limulus ventral photoreceptors.
Johnson EC; Gray-Keller MP; O'Day PM
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(52):33100-33104
Functional coupling of a human retinal metabotropic glutamate receptor (hmGluR6) to bovine rod transducin and rat Go in an in vitro reconstitution system.
Weng K; Lu C; Daggett LP; Kuhn R; Flor PJ; Johnson EC; Robinson PR
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1997;280(1):346-356
Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
Chavez-Noriega LE; Crona JH; Washburn MS; Urrutia A; Elliott KJ; Johnson EC
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1996;279(1):367-378
Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells.
Varney MA; Jachec C; Deal C; Hess SD; Daggett LP; Skvoretz R; Urcan M; Morrison JH; Moran T; Johnson EC; Veliçelebi G
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1996;278(2):808-816
Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
Hess SD; Daggett LP; Crona J; Deal C; Lu CC; Urrutia A; Chavez-Noriega L; Ellis SB; Johnson EC; Veliçelebi G
Article: JOURNAL OF MOLECULAR NEUROSCIENCE. 1996;7(3):217-228
Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.
Elliott KJ; Ellis SB; Berckhan KJ; Urrutia A; Chavez-Noriega LE; Johnson EC; Veliçelebi G; Harpold MM
Article: JOURNAL OF NEUROSCIENCE. 1995;15(10):6586-6591
Inhibitors of cyclic-GMP phosphodiesterase alter excitation of Limulus ventral photoreceptors in Ca(2+)-dependent fashion.
Johnson EC; O'Day PM
Article: NEUROPHARMACOLOGY. 1995;34(8):871-886
Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5.
Daggett LP; Sacaan AI; Akong M; Rao SP; Hess SD; Liaw C; Urrutia A; Jachec C; Ellis SB; Dreessen J
Article: NEUROPHARMACOLOGY. 1995;34(7):753-765
Characteristics of a human N-type calcium channel expressed in HEK293 cells.
Bleakman D; Bowman D; Bath CP; Brust PF; Johnson EC; Deal CR; Miller RJ; Ellis SB; Harpold MM; Hans M
Show more

All other publications

Editorial comment: JOURNAL OF NEUROCHEMISTRY. 2011;119(5):896-898
N-acetylaspartylglutamate is not demonstrated to be a selective mGlu₃receptor agonist.
Johnson EC
Meeting abstract: BIOCHEMICAL PHARMACOLOGY. 2011;82(8):1040-1041
Attentional improvement in rats with the nicotinic agonist AZ12564698 (AZD3480)
Rezvani AH; Cauley M; Johnson E; Levin ED
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2011;21:S253-S254
Mechanisms of antidepressant activity for TC-5214: a selective, centrally-acting neuronal nicotinic channel modulator
Quirk M; Johnson E; Moore WC; Doherty J; Bertrand D
Published conference paper: BIOCHEMICAL PHARMACOLOGY. 2009;78(7):880-888
Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.
Sydserff S; Sutton EJ; Song D; Quirk MC; Maciag C; Li C; Jonak G; Gurley D; Gordon JC; Christian EP; Doherty JJ; Hudzik T; Johnson E; Mrzljak L; Piser T; Smagin GN; Wang Y; Widzowski D; Smith JS
Review: CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2005;5(9):897-911
Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications.
Slassi A; Isaac M; Edwards L; Minidis A; Wensbo D; Mattsson J; Nilsson K; Raboisson P; McLeod D; Stormann TM; Hammerland LG; Johnson E
Published conference paper: NEUROPHARMACOLOGY. 1999;38(10):1493-1503
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
Gasparini F; Lingenhöhl K; Stoehr N; Flor PJ; Heinrich M; Vranesic I; Biollaz M; Allgeier H; Heckendorn R; Urwyler S; Varney MA; Johnson EC; Hess SD; Rao SP; Sacaan AI; Santori EM; Veliçelebi G; Kuhn R
Review: METHODS IN MOLECULAR BIOLOGY. 1999;128:43-59
Stable expression of human NMDA receptors in cultured mammalian cells.
Varney MA; Lin FF; Jachec C; Rao SP; Hess SD; Johnson EC; Veliçelebi G

Articles

All other publications

News from KI

Events from KI